{
    "nctId": "NCT05448209",
    "briefTitle": "The Effect of Walking Exercise Based on TOUS on Peripheral Neuropathy and Arthralgia-Myalgia in Women With Breast Cancer",
    "officialTitle": "The Effect of Walking Exercise Based on the Theory of Disturbing Symptoms in Women With Breast Cancer Receiving Paclitaxel on Peripheral Neuropathy and Arthralgia-Myalgia: A Randomized Controlled Pilot Application",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Peripheral Neuropathies, Arthralgia, Myalgia",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 82,
    "primaryOutcomeMeasure": "Chemotherapy-Induced Peripheral Neuropathy Assessment Tool (CIPNAT)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 18 years and over,\n* Eastern Cooperative Oncology Group (ECOG) Status 0 to 1\n* Receiving Paclitaxel or Paclitaxel-Herceptin\n* Patients with 12 weeks defined in the protocol will be included.\n\nExclusion Criteria:\n\n* Those with open wounds and edema on their hands and feet\n* Patients with diabetes mellitus and peripheral neuropathy due to autoimmune disease\n* Use other complementary therapies to prevent peripheral neuropathy throughout the treatment process.\n* Conditions that limit exercise such as cardiovascular, pulmonary, musculoskeletal system\n* Those with psychological and communication problems",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}